» Articles » PMID: 33367961

Population Pharmacodynamic Modeling Using the Sigmoid E Model: Influence of Inter-individual Variability on the Steepness of the Concentration-Effect Relationship. a Simulation Study

Overview
Journal AAPS J
Specialty Pharmacology
Date 2020 Dec 28
PMID 33367961
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between the concentration of a drug and its pharmacological effect is often described by empirical mathematical models. We investigated the relationship between the steepness of the concentration-effect relationship and inter-individual variability (IIV) of the parameters of the sigmoid E model, using the similarity between the sigmoid E model and the cumulative log-normal distribution. In addition, it is investigated whether IIV in the model parameters can be estimated accurately by population modeling. Multiple data sets, consisting of 40 individuals with 4 binary observations in each individual, were simulated with varying values for the model parameters and their IIV. The data sets were analyzed using Excel Solver and NONMEM. An empirical equation (Eq. (11)) was derived describing the steepness of the population-predicted concentration-effect profile (γ*) as a function of γ and IIV in C50 and γ, and was validated for both binary and continuous data. The tested study design is not suited to estimate the IIV in C50 and γ with reasonable precision. Using a naive pooling procedure, the population estimates γ* are significantly lower than the value of γ used for simulation. The steepness of the population-predicted concentration-effect relationship (γ*) is less than that of the individuals (γ). Using γ*, the population-predicted drug effect represents the drug effect, for binary data the probability of drug effect, at a given concentration for an arbitrary individual.

Citing Articles

Synergistic Effects of Korean Mistletoe and Apple Peel Extracts on Muscle Strength and Endurance.

Kang Y, Kwon J, Kwon S, Kim A Nutrients. 2024; 16(19).

PMID: 39408221 PMC: 11478607. DOI: 10.3390/nu16193255.


Exposure-response analysis using time-to-event data for bevacizumab biosimilar SB8 and the reference bevacizumab.

Park S, Jung J, Ju S, Lim H Front Pharmacol. 2024; 14:1288308.

PMID: 38293674 PMC: 10825021. DOI: 10.3389/fphar.2023.1288308.

References
1.
Bouillon T . Hypnotic and opioid anesthetic drug interactions on the CNS, focus on response surface modeling. Handb Exp Pharmacol. 2008; (182):471-87. DOI: 10.1007/978-3-540-74806-9_22. View

2.
Short T, Ho T, Minto C, Schnider T, Shafer S . Efficient trial design for eliciting a pharmacokinetic-pharmacodynamic model-based response surface describing the interaction between two intravenous anesthetic drugs. Anesthesiology. 2002; 96(2):400-8. DOI: 10.1097/00000542-200202000-00027. View

3.
Hannivoort L, Vereecke H, Proost J, Heyse B, Eleveld D, Bouillon T . Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil. Br J Anaesth. 2016; 116(5):624-31. DOI: 10.1093/bja/aew060. View

4.
Lu W, BAILEY J . Reliability of pharmacodynamic analysis by logistic regression: a computer simulation study. Anesthesiology. 2001; 92(4):985-92. DOI: 10.1097/00000542-200004000-00015. View

5.
Sheiner L, Stanski D, Vozeh S, Miller R, Ham J . Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther. 1979; 25(3):358-71. DOI: 10.1002/cpt1979253358. View